Table 1.

Pretreatment patient characteristics

Part IPart II
AB
Sex
 Male366
 Female326
Age (y), median (range)66 (28–74)72 (29–81)58 (37–67)
AJCC staging
 IIB  1
 IIC
 IIIA  14
 IIIB123
 IIIC212
 IV242
NY-ESO-1 expression in tumors113